REG - Surgical Innovations - Director/PDMR Shareholding <Origin Href="QuoteRef">SUNU.L</Origin>

Surgical InnovationsAnnouncement

03/04/2017 11:30

RNS Number : 3768B
Surgical Innovations Group PLC
03 April 2017
Surgical Innovations Group plc
("the Company")
Director/PDMR Shareholding
The Company was notified on 31 March 2017 that on that day, Melanie Ross, Chief Operating Officer, disposed of 605,714 ordinary shares of 1 penny each ("Shares") at a price of 3.55p per share.
In addition, Melanie Ross purchased 340,714 ordinary shares for her ISA and her husband, Lee Ross purchased 265,000 ordinary shares for his ISA, at a price of 3.555p per share.
Additionally, on the same day Melanie Ross transferred 265,000 ordinary shares to Lee Ross for nil
consideration.
Following the transactions, there has been no change to the combined beneficial holding of Melanie Ross and her husband in the Company and has remained at 1,240,377 shares, representing approximately 0.23% of the issued share capital of the Company.
The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on shares acquired. 
For further information please contact:
Surgical Innovations Group Plc
www.sigroupplc.com
Nigel Rogers, Executive Chairman 
Tel: 0113 230 7597
Melanie Ross, COO & Finance Director 



WH Ireland Limited (NOMAD & Broker)

Tim Feather
Tel: 0113 394 6600
Walbrook PR (Financial PR & Investor Relations)
Tel: 020 7933 8780 or si@walbrookpr.com
Paul McManus
Mob: 07980 541893
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Melanie Ross
2
Reason for the notification
a)
Position/status
Chief Operating Officer, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
1. Sale of shares 
2. Transfer of shares to husband
c)
Price(s) and volume(s)

Price(s)
Volume(s)
1.
3.55p
605,714
2.
Nil
265,000
d)
Aggregated information
- Aggregated volume
- Price
As per 4(c) above
e)
Date of the transaction
31 March 2017
f)
Place of the transaction
London Stock Exchange, AIM
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Melanie Ross
2
Reason for the notification
a)
Position/status
Chief Operating Officer, Surgical Innovations Group plc
b)
Initial notification/ Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Surgical Innovations Group plc
b)
LEI
N/A
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 1p
GB0004016704
b)
Nature of the transactions
1. Purchase of shares in ISA
2. Purchase of shares by husband
c)
Price(s) and volume(s)

Price(s)
Volume(s)
1.
3.555p
340,714
2.
3.555p
265,000
d)
Aggregated information
- Aggregated volume
- Price
605,714
21,533
e)
Date of the transaction
31 March 2017
f)
Place of the transaction
London Stock Exchange, AIM

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHBGGDSXDGBGRX